Immunoreactive corticotropin-releasing factor in human plasma

94Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Plasma immunoreactive corticotropin-releasing factor (I-CRF) levels were determined by using a human CRF radioimmunoassay and an immunoaffinity procedure. The basal plasma I-CRF level in normal subjects was 6 ± 0.5 pg/ml (mean ±SD). We found that most plasma I-CRF levels were affected by stress, negative feedback, and circadian rhythm. Basal I-CRF levels were high in patients with Addison's disease, Nelson's syndrome, hypopituitarism stemming from pituitary macroadenoma, and CRF- and adrenocorticotropic hormone-producing tumors. A very low, but significant, amount of I-CRF was detected (1-3 pg/ml) in patients with Cushing's syndrome, in corticosteroid-treated patients, and in a patient with hypothalamic hypopituitarism. These results suggest that a major component of plasma I-CRF is of hypothalamic origin, however, other extrahypothalamic tissues cannot be ruled out as a minor source of plasma I-CRF.

Cite

CITATION STYLE

APA

Suda, T., Tomori, N., Yajima, F., Sumitomo, T., Nakagami, Y., Ushiyama, T., … Shizume, K. (1985). Immunoreactive corticotropin-releasing factor in human plasma. Journal of Clinical Investigation, 76(5), 2026–2029. https://doi.org/10.1172/JCI112204

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free